Teva names Bhattacharjee as generics group head, replacing Olafsson

Teva names Bhattacharjee as generics group head, replacing Olafsson


Dec 6 Teva Pharmaceutical Industries , the world's biggest generic drugmaker, has appointed Dipankar Bhattacharjee as chief executive for its global generic medicines group, replacing Siggi Olafsson. Bhattacharjee, who has served as CEO of Teva Generics Europe since April 2013, will replace Olafsson, who will retire at the end of the first quarter of 2017.



from Biotech News